Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Terminology supported archiving and publication of environmental science data in PANGAEA.

Diepenbroek M, Schindler U, Huber R, Pesant S, Stocker M, Felden J, Buss M, Weinrebe M.

J Biotechnol. 2017 Nov 10;261:177-186. doi: 10.1016/j.jbiotec.2017.07.016. Epub 2017 Jul 23. Review.

2.

Blood pressure-independent effect of long-term treatment with the soluble heme-independent guanylyl cyclase activator HMR1766 on progression in a model of noninflammatory chronic renal damage.

Benz K, Orth SR, Simonaviciene A, Linz W, Schindler U, Rütten H, Amann K.

Kidney Blood Press Res. 2007;30(4):224-33. Epub 2007 Jun 15.

3.

Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase.

Schindler U, Strobel H, Schönafinger K, Linz W, Löhn M, Martorana PA, Rütten H, Schindler PW, Busch AE, Sohn M, Töpfer A, Pistorius A, Jannek C, Mülsch A.

Mol Pharmacol. 2006 Apr;69(4):1260-8. Epub 2005 Dec 6.

PMID:
16332991
4.

Effects of combined inhibition of the Na+-H+ exchanger and angiotensin-converting enzyme in rats with congestive heart failure after myocardial infarction.

Ruetten H, Gehring D, Hiss K, Schindler U, Gerl M, Busch AE, Schaefer S.

Br J Pharmacol. 2005 Nov;146(5):723-31.

5.

Inhibition of Na+-H+ exchange by cariporide reduces inflammation and heart failure in rabbits with myocardial infarction.

Rungwerth K, Schindler U, Gerl M, Schäfer S, Licher T, Busch AE, Ruetten H.

Br J Pharmacol. 2004 Aug;142(7):1147-54. Epub 2004 Jul 5.

6.

Molecular mechanisms of repression of eotaxin expression with fluticasone propionate in airway epithelial cells.

Matsukura S, Kokubu F, Kurokawa M, Kawaguchi M, Kuga H, Ieki K, Odaka M, Suzuki S, Watanabe S, Takeuchi H, Schleimer RP, Schindler U, Adachi M.

Int Arch Allergy Immunol. 2004 Jun;134 Suppl 1:12-20.

PMID:
15166478
7.

Differential roles of C-terminal activation motifs in the establishment of Stat6 transcriptional specificity.

Goenka S, Marlar C, Schindler U, Boothby M.

J Biol Chem. 2003 Dec 12;278(50):50362-70. Epub 2003 Sep 30.

8.
9.

Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat.

Di Sario A, Bendia E, Taffetani S, Marzioni M, Candelaresi C, Pigini P, Schindler U, Kleemann HW, Trozzi L, Macarri G, Benedetti A.

Hepatology. 2003 Feb;37(2):256-66.

PMID:
12540775
10.

Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M.

Broxmeyer HE, Bruns HA, Zhang S, Cooper S, Hangoc G, McKenzie AN, Dent AL, Schindler U, Naeger LK, Hoey T, Kaplan MH.

Immunity. 2002 Jun;16(6):815-25.

11.

Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism.

Matsukura S, Stellato C, Georas SN, Casolaro V, Plitt JR, Miura K, Kurosawa S, Schindler U, Schleimer RP.

Am J Respir Cell Mol Biol. 2001 Jun;24(6):755-61.

PMID:
11415942
12.

Cutting edge: FISP (IL-4-induced secreted protein), a novel cytokine-like molecule secreted by Th2 cells.

Schaefer G, Venkataraman C, Schindler U.

J Immunol. 2001 May 15;166(10):5859-63.

13.

DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites.

Ehret GB, Reichenbach P, Schindler U, Horvath CM, Fritz S, Nabholz M, Bucher P.

J Biol Chem. 2001 Mar 2;276(9):6675-88. Epub 2000 Oct 26.

14.
15.

A gain-of-function mutation in STAT6.

Daniel C, Salvekar A, Schindler U.

J Biol Chem. 2000 May 12;275(19):14255-9.

16.

DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites.

Soldaini E, John S, Moro S, Bollenbacher J, Schindler U, Leonard WJ.

Mol Cell Biol. 2000 Jan;20(1):389-401.

17.

Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.

Wohlfart P, Malinski T, Ruetten H, Schindler U, Linz W, Schoenafinger K, Strobel H, Wiemer G.

Br J Pharmacol. 1999 Nov;128(6):1316-22.

18.

Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation.

Goenka S, Youn J, Dzurek LM, Schindler U, Yu-Lee LY, Boothby M.

J Immunol. 1999 Nov 1;163(9):4663-72.

19.

Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression.

Dickensheets HL, Venkataraman C, Schindler U, Donnelly RP.

Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10800-5.

20.

Repression of IL-4-induced gene expression by IFN-gamma requires Stat1 activation.

Venkataraman C, Leung S, Salvekar A, Mano H, Schindler U.

J Immunol. 1999 Apr 1;162(7):4053-61.

21.

Stat6 inhibits human interleukin-4 promoter activity in T cells.

Georas SN, Cumberland JE, Burke TF, Chen R, Schindler U, Casolaro V.

Blood. 1998 Dec 15;92(12):4529-38.

22.

STAT structure and function in signaling.

Hoey T, Schindler U.

Curr Opin Genet Dev. 1998 Oct;8(5):582-7. Review.

PMID:
9794817
23.

Synergistic activation of the germline epsilon promoter mediated by Stat6 and C/EBP beta.

Mikita T, Kurama M, Schindler U.

J Immunol. 1998 Aug 15;161(4):1822-8.

24.

Mutational analysis of the STAT6 SH2 domain.

Mikita T, Daniel C, Wu P, Schindler U.

J Biol Chem. 1998 Jul 10;273(28):17634-42.

25.

Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression.

Kaplan MH, Daniel C, Schindler U, Grusby MJ.

Mol Cell Biol. 1998 Apr;18(4):1996-2003.

26.

Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor alpha gene transcription.

Meyer WK, Reichenbach P, Schindler U, Soldaini E, Nabholz M.

J Biol Chem. 1997 Dec 12;272(50):31821-8.

27.

A high-throughput STAT binding assay using fluorescence polarization.

Wu P, Brasseur M, Schindler U.

Anal Biochem. 1997 Jun 15;249(1):29-36.

PMID:
9193705
28.

No .NO from NO synthase.

Schmidt HH, Hofmann H, Schindler U, Shutenko ZS, Cunningham DD, Feelisch M.

Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14492-7.

29.

Requirements for interleukin-4-induced gene expression and functional characterization of Stat6.

Mikita T, Campbell D, Wu P, Williamson K, Schindler U.

Mol Cell Biol. 1996 Oct;16(10):5811-20.

30.

Is screening of metastases based on symptoms effective in breast cancer patients?

Jäger W, Binder H, Schindler U, Krämer S, Palapelas V.

Anticancer Res. 1996 Sep-Oct;16(5B):3169-71.

PMID:
8920786
31.
32.

Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.

Kaplan MH, Schindler U, Smiley ST, Grusby MJ.

Immunity. 1996 Mar;4(3):313-9.

33.

IL-4 Signaling Mechanisms in Inflammatory Bowel Disease Mononuclear Phagocytes.

Rückert Y, Schindler U, Heinig T, Nikolaus S, Raedler A, Schreiber S.

Inflamm Bowel Dis. 1996 Winter;2(4):244-52.

PMID:
23282589
34.

Detection of dihydrotestosterone (DHT) doping: alterations in the steroid profile and reference ranges for DHT and its 5 alpha-metabolites.

Donike M, Ueki M, Kuroda Y, Geyer H, Nolteernsting E, Rauth S, Schänzer W, Schindler U, Völker E, Fujisaki M.

J Sports Med Phys Fitness. 1995 Dec;35(4):235-50.

PMID:
8776070
35.

The G-box: a ubiquitous regulatory DNA element in plants bound by the GBF family of bZIP proteins.

Menkens AE, Schindler U, Cashmore AR.

Trends Biochem Sci. 1995 Dec;20(12):506-10. Review.

PMID:
8571452
36.

Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.

Fujii H, Nakagawa Y, Schindler U, Kawahara A, Mori H, Gouilleux F, Groner B, Ihle JN, Minami Y, Miyazaki T, et al.

Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5482-6.

37.

Components of a Stat recognition code: evidence for two layers of molecular selectivity.

Schindler U, Wu P, Rothe M, Brasseur M, McKnight SL.

Immunity. 1995 Jun;2(6):689-97.

38.

Identification and purification of human Stat proteins activated in response to interleukin-2.

Hou J, Schindler U, Henzel WJ, Wong SC, McKnight SL.

Immunity. 1995 Apr;2(4):321-9.

39.

An interleukin-4-induced transcription factor: IL-4 Stat.

Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL.

Science. 1994 Sep 16;265(5179):1701-6.

PMID:
8085155
41.

The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation.

Münch G, Taneli Y, Schraven E, Schindler U, Schinzel R, Palm D, Riederer P.

J Neural Transm Park Dis Dement Sect. 1994;8(3):193-208.

PMID:
7748463
42.

HAT3.1, a novel Arabidopsis homeodomain protein containing a conserved cysteine-rich region.

Schindler U, Beckmann H, Cashmore AR.

Plant J. 1993 Jul;4(1):137-50.

43.
45.

DNA binding site preferences and transcriptional activation properties of the Arabidopsis transcription factor GBF1.

Schindler U, Terzaghi W, Beckmann H, Kadesch T, Cashmore AR.

EMBO J. 1992 Apr;11(4):1275-89.

46.

Heterodimerization between light-regulated and ubiquitously expressed Arabidopsis GBF bZIP proteins.

Schindler U, Menkens AE, Beckmann H, Ecker JR, Cashmore AR.

EMBO J. 1992 Apr;11(4):1261-73.

47.

Nuclear factors binding to the extensin promoter exhibit differential activity in carrot protoplasts and cells.

Granell A, Peretó JG, Schindler U, Cashmore AR.

Plant Mol Biol. 1992 Feb;18(4):739-48.

PMID:
1558947
49.
50.

Supplemental Content

Loading ...
Support Center